Abstract: This article is concerned with a recursive remote estimation problem for a class of nonlinear complex networks subject to the token bucket protocol (TBP) and amplify-and-forward (AF) relays.
Recursive Agents implements a three-phase iterative refinement architecture where LLM agents (instances of Classes) critique and improve their own outputs. Unlike single-pass systems, each agent ...
CNBC’s Jim Cramer answers calls from viewers and offers advice for their stock picks. Secret Service finds 17 'skimming' devices in tour of San Antonio businesses Trump just kneecapped the GOP’s ...
Recursion Pharmaceuticals stock jumped 16% on October 8, 2025, reaching around $6.08 after falling 5.4% the previous day on broader market weakness. The company reported Q2 2025 revenue of $19.2 ...
Abstract: Multi-modal image synthesis is crucial for obtaining complete modalities due to the imaging restrictions in reality. Current methods, primarily CNN-based models, find it challenging to ...
Abstract: This article addresses the problem of secure recursive state estimation for a networked linear system, which may be vulnerable to interception of transmitted measurement data by ...
Abstract: This article studies the recursive state estimator-based fuzzy adaptive control scheme for discrete-time uncertain nonlinear systems with state saturations and missing measurements. A fuzzy ...
Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage assets. RXRX's AI-driven drug discovery model is ambitious, but pipeline value ...
Costco’s stock remained steady, closing at $914.80 with no percentage change. The stock reached an intraday high of $916.38 and a low of $910.96, while its 52-week high and low are $1078.23 and ...
Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...
The authors do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback